These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10208649)

  • 1. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
    Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
    Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
    Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
    Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I
    Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
    Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
    McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.
    Jaskuła-Sztul R; Sokołowski W; Gajecka M; Szyfter K
    J Appl Genet; 2001; 42(2):223-31. PubMed ID: 14564055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
    Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.